Tag Archives: SCLC

December, 2018

November, 2018

October, 2018

August, 2018

June, 2018

April, 2018

April, 2017

  • 17 April

    OncoMed’s Tarextumab Misses Primary Endpoint in Mid-Stage Lung Cancer Trial

    REDWOOD CITY, Calif., April 17, 2017 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics, today reported top-line results from the company’s randomized 145-patient Phase 2 PINNACLE clinical trial of tarextumab (anti-Notch2/3, OMP-59R5) in combination with …